Acetadote is an intravenous (IV) formulation of N-acetylcysteine (NAC) indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen 1. Cumberland ...

Acetadote is an intravenous (IV) formulation of N-acetylcysteine (NAC) indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen1. Acetaminophen ...

NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, ...

Cumberland Pharmaceuticals' stock is one of the leading gainers today, surging over 90% in value. Moreover, in the past month we've seen the stock jumping a whopping 101%. Cumberland Stock Soars ...

Credit: Getty Images. The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions. Certain factors should be considered ...

Acetadote is supplied as a 20% solution (200mg/mL) in a 30mL single-dose vial that must be diluted prior to intravenous administration. Total injection volume will vary based on the patient’s ...

Cumberland (CPIX) Pharmaceuticals announced the FDA has approved a supplemental New Drug Application for its Acetadote product. Acetadote is an intravenous formulation of N-acetylcysteine ...

Acetadote is an intravenous (IV) formulation of N-acetylcysteine (NAC) indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen1. Acetaminophen, a ...

Acetadote is used in hospital emergency departments to prevent or lessen the risk of liver damage following an acetaminophen overdose, which is often caused by overuse of over-the-counter pain ...